Heron Therapeutics Inc. (HRTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Heron Therapeutics Inc.

    NASDAQ: HRTX · Real-Time Price · USD
    1.21
    -0.01 (-0.41%)
    At close: Sep 26, 2025, 3:59 PM
    1.21
    0.00%
    After-hours: Sep 26, 2025, 07:34 PM EDT

    Heron Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -17.18 -2.12 -1.5 -4.07
    PEG Ratio
    		 0.19 0.04 0.06 0.39
    PS Ratio
    		 1.62 1.85 2.53 10.41
    PB Ratio
    		 -6.93 -6.91 20.06 11.59
    P/FCF Ratio
    		 -9.62 -3.89 -1.83 -4.36
    P/OCF Ratio
    		 -10.35 -3.99 -1.85 -4.42
    OCF/S Ratio
    		 -0.16 -0.46 -1.36 -2.36
    Debt / Equity Ratio
    		 -5.28 -5.29 11.60 2.06
    Quick Ratio
    		 1.70 1.84 1.83 2.90
    Current Ratio
    		 2.29 2.37 2.49 3.58
    Asset Turnover
    		 0.62 0.57 0.43 0.28
    Interest Coverage
    		 -1.91 -28.6 -70.6 -90.39
    Return on Equity
    		 0.40 3.25 -13.41 -2.84
    Return on Assets
    		 -0.06 -0.5 -0.73 -0.72
    Return on Invested Capital
    		 -0.08 -0.74 -0.74 -0.9
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.73 0.49 0.49 0.47
    Net Profit Margin
    		 -0.09 -0.87 -1.69 -2.56
    Pretax Profit Margin
    		 -0.09 -0.87 -1.69 -2.56
    Operating Profit Margin
    		 -0.08 -0.87 -1.62 -2.52
    FCF Margin
    		 -0.17 -0.47 -1.38 -2.39
    EBITDA Margin
    		 -0.04 -0.82 -1.64 -2.49

    Add to Watchlist